They are setting up a huge global supply chain to support massive growth in demand for their first product which will likely grow to $1.5b annual revenue.
Next year they will have 3 products on the market.
It's all only the US at the moment. ROW is coming starting this year.
This is only their embedded equivalent ' discreet is coming within 2 years in the form of therapy which garners 10× the revenue of diagnostic.
They're running 30 clinical trials covering a plethora of cancers all of which have an extremely high probability of success with another product to market.
Massive growth to continue and no CRs ever.
20 to 30 bags likely IMO.
Likely 2028 before WBT has a billion revenue. Next year for TLX.
Both great stocks but with completely different time horizons.
Ann: Weebit Nano Q4 FY22 Activities Report and Appendix 4C, page-69
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.55 |
Change
0.120(4.94%) |
Mkt cap ! $481.4M | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.65 | $2.46 | $3.607M | 1.405M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8185 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 14261 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| WBT (ASX) Chart |